0000904454-24-000112.txt : 20240206
0000904454-24-000112.hdr.sgml : 20240206
20240206172839
ACCESSION NUMBER: 0000904454-24-000112
CONFORMED SUBMISSION TYPE: 5
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231231
FILED AS OF DATE: 20240206
DATE AS OF CHANGE: 20240206
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kaye Jack
CENTRAL INDEX KEY: 0001376099
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 5
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36294
FILM NUMBER: 24601348
MAIL ADDRESS:
STREET 1: C/O KERYX BIOPHARMACEUTICALS
STREET 2: 750 LEXINGTON AVENUE
CITY: NEW YORK
STATE: X1
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: uniQure N.V.
CENTRAL INDEX KEY: 0001590560
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: PAASHEUVELWEG 25A
CITY: AMSTERDAM
STATE: P7
ZIP: 1105 BP
BUSINESS PHONE: 1-339-970-7000
MAIL ADDRESS:
STREET 1: PAASHEUVELWEG 25A
CITY: AMSTERDAM
STATE: P7
ZIP: 1105 BP
FORMER COMPANY:
FORMER CONFORMED NAME: uniQure B.V.
DATE OF NAME CHANGE: 20131030
5
1
ownership.xml
X0508
5
2023-12-31
0
0
1
0001590560
uniQure N.V.
QURE
0001376099
Kaye Jack
C/O UNIQURE N.V.
PAASHEUVELWEG 25A
AMSTERDAM
P7
11058BP
NETHERLANDS
1
0
0
0
0
Ordinary Shares
2023-06-23
4
G
0
L
12700
0
D
21419
D
Ordinary Shares
2023-06-23
4
G
0
L
12700
0
D
8719
D
On June 23, 2023, the Reporting Person, in connection with his estate plan, made a gift of 12,700 shares to each of his adult children. These were bona fide gifts for no consideration. Mr. Kaye has not retained any voting or dispositive power over such gifted shares.
/s/ Christian Klemt, Attorney-in-Fact
2024-02-06